findmyKOL

Celso Tello, MD

Basic profile

Northwell Health

ORCID↗NPI↗
✓ Full record
RegionNew York, NY · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: RegionalLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Celso Tello is an Ophthalmology physician affiliated with Northwell Health. OpenAlex indexes 248 publications with 5,079 citations (h-index 41).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
248publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,079citations

Total citations across indexed works.

41h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

310 E 14th St
Suite #304
New York, NY 100034201

Telephone

212-477-7540

Registry record last updated 26 Jun 2012.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85.9%
    Prostaglandin Analog36.8%
    Latanoprost56%Lumigan22%Travoprost14%Zioptan4%Travatan Z2%Tafluprost2%Bimatoprost1%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor25.6%
    Dorzolamide-Timolol42%Simbrinza22%Dorzolamide Hcl16%Brinzolamide15%Cosopt Pf3%Azopt3%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    10.6%
    Beta blocker10.6%
    Timolol Maleate98%Betaxolol Hcl3%
    Part D<11 patients
  • Musculoskeletal

    2.1%
    Cyclooxygenase Inhibitor2.1%
    Ketorolac Tromethamine100%
    Part D≥61 patients
Where care is delivered (Part B)1.7% facility · 98.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”